Generic Pharmaceutical Business Investment Opportunities

Business is located in Bhubaneswar, specializing in the development of drugs that induce endogenous nitric oxide in humans and animals. - Company is incubated in a well-known biotechnological institute in Bhubaneswar, Orissa. - Company has successfully completed the research to identify the chemical structure of the drug that can induce nitric oxide production and is now seeking funding to proceed with development. - Research findings are patented and protected in India, USA, and EU, providing the company with a competitive advantage in the market. - The company is ready to commence the development phase upon securing the necessary funding, presenting an opportunity for potential investors to participate in an innovative and potentially lucrative venture in the pharmaceutical and nutraceutical industry. - Promoter is a medical researcher and has 50 years of experience. - The company is registered with the Ministry of Corporate Affairs (MCA), ensuring compliance with regulatory and legal requirements.

Business is located in Bhubaneswar, specializing in the development of drugs that induce endogenous nitric oxide in humans and animals. - Company is incubated in a well-known biotechnological institute in Bhubaneswar, Orissa. - Company has successfully completed the research to identify the chemical structure of the drug that can induce nitric oxide production and is now seeking funding to proceed with development. - Research findings are patented and protected in India, USA, and EU, providing the company with a competitive advantage in the market. - The company is ready to commence the development phase upon securing the necessary funding, presenting an opportunity for potential investors to participate in an innovative and potentially lucrative venture in the pharmaceutical and nutraceutical industry. - Promoter is a medical researcher and has 50 years of experience. - The company is registered with the Ministry of Corporate Affairs (MCA), ensuring compliance with regulatory and legal requirements.

The business operates in the pharmaceutical and medical devices export industry, focusing on therapies such as anaemia management, nephrology, and gynaecology. - With a current staff of 6 permanent employees, the business has made significant strides in increasing its client base, growing from 2 clients in the last fiscal year to 15 clients in the current fiscal year. - The company has outlined a road-map to achieve a turnover of 100 crore in the next 2 fiscal years, indicating a strong growth trajectory. - Initially starting as a short-term trading model, the business is now transitioning towards brand building and is in the process of registering its brand in 4 countries, showcasing a strategic shift in its business model. - The product portfolio comprises 80% medicines and 20% medical devices, with a focus on exporting these products to countries such as Zambia, Uganda, and Kenya. - The business sources medicines and equipment from India and exports them to international markets, highlighting its role in facilitating the global distribution of pharmaceutical and medical devices. - With a valid GST certificate for operations, the business is compliant with regulatory requirements, adding a layer of credibility to its operations.

Pharma manufacturing company, located in Nashik. - The plant is in its final stage of commissioning and will focus on the production of small volume parenterals in ampules, vials, PFS, and lyophilized products. - Technical inspection is pending, post which the business can obtain drug manufacturing license to start the manufacturing process. - Will be manufactured on a principle-to-principle and loan license basis for both local and export markets. - The product line includes human injectable products falling under drug categories such as antibiotics, steroids, analgesics etc. - Business model involves manufacturing products under the brand and formulation of other major pharmaceutical companies and supplying them for marketing and distribution. - The business is registered with the Ministry of Corporate Affairs (MCA), holds a Permanent Account Number (PAN), and is registered with the Micro, Small, and Medium Enterprises (MSME).

Business owner of a drug wholesale business planning to establish a pharmaceutical drug manufacturing plant. - The focus will be on creating a portfolio of drugs under the company's own brand name. - Initially, the manufacturing will concentrate on oral tablets and capsules, with future plans for expansion into other drug categories. - The company aims to supply its products to distributors across West Bengal, Jharkhand, Bihar, and Odisha. - Raw materials for the manufacturing process will be sourced from Ahmedabad and Visakhapatnam. - Will be obtaining drug license and FDA approval once the business launches.

The project is to manufacture and supply tablets to the government of Sri Lanka up to 860mln per annum on a buyback guarantee and cost plus 20% margin. - The company can sell also in the private market which has a 40% profit margin. - Own 9.25-acre land valued at USD 1mln approx. - The license is issued and a government buyback agreement is signed. - The project is in plug and play stage where the investor can mobilize immediately. - Commercial manufacturing can commence in 8 months.

Our research and development department reflects our full commitment to delivering to society. - The revolutionary pharmaceuticals, acquired through groundbreaking ideas and high-standard research and development by each individual employee challenge innovation, so as to help enable patients and their families to lead healthier and more fulfilling lives. It also expresses our corporate mission symbolically, cooperating with a wide range of companies worldwide. - With a wide variety of drugs and a tradition in manufacturing for needs, we have cooperated with companies from Spain, Italy, and Turkey, looking forward to offering a wide range of healthcare products, also for well-being, with pre-ordered dosage forms for your efficiency and gut health. - The promoter is an investor representing the company who is based out of Istanbul.

Well established pharmaceutical company that has been operational for over 22 years. - Company manufactures and sells generic medicines under our own brand name. - Company has 3 directors and has no liability. - Business has its own manufacturing facility and has also partnered with other manufacturers to produce medicines. - Medicines are sold to doctors, pharma chains and distributors.